Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Endocrine Practice

• Publication date

  2006-08-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP.12.4.358PMID 16901792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperglycemia in the Hospital Setting: The Case for Improved Control among Non-Diabetics

  2005cited by this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cited by this paper
• Steroid‐Induced Diabetes Mellitus and Related Risk Factors in Patients with Neurologic Diseases

  2004cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper
• Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Is enough attention being given to the adverse effects of corticosteroid therapy?

  2000cited by this paper
• Drug selection and the management of corticosteroid-related diabetes mellitus.

  1999cited by this paper
• Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies.

  1998cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper

• Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Following Ophthalmic Steroid Use: A Rare Etiology

  2026cites this paper
• Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)

  2025cites this paper
• A qualitative study to explore experiences and views of patients and their family members managing steroid‐induced hyperglycaemia (SIH) out of hospital

  2025cites this paper
• Zeitlich eingeschränkte Nahrungsaufnahme und Bewegung - effektiver im Doppelpack?

  2025cites this paper
• Dapagliflozin prevents glucocorticoid‐induced hyperglycaemia: Results from the DAPACOID Phase II Clinical Trial

  2025cites this paper
• Mit Metformin Glukokortikoid-Nebenwirkungen reduzieren?

  2025cites this paper
• Safety of steroids in severe community-acquired pneumonia

  2025cites this paper
• Type 2 diabetes mellitus and hyperglycemia among hospitalized COVID-19 patients: A single center study from Lebanon

  2025cites this paper
• Complications Associated with Glucocorticoids Treatment in Critically Ill Patients

  2025cites this paper
• Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion

  2025cites this paper
• The risk of type 2 diabetes among older Asian, Native Hawaiian and Pacific Islander colorectal cancer survivors:a population-based study using SEER-Medicare database.

  2025cites this paper
• Diabète et hypercortisolisme

  2025cites this paper
• Impact of type 2 and steroid-Induced diabetes mellitus on prognosis in patients with multiple myeloma

  2025cites this paper
• Interplay Between Diabetes, Obesity and Glioblastoma Multiforme, and the Role of Nanotechnology in Its Treatment

  2025cites this paper
• Kajian Literatur: Faktor Risiko Glucocorticoid-induced Diabetes Mellitus (GIDM) pada pasien SLE

  2025cites this paper
• Postoperative outcomes of biopsy versus debulking surgery for immunoglobulin G4-related ophthalmic disease: a retrospective comparative study

  2025cites this paper
• Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

  2025cites this paper
• Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood–Brain Barrier and Blood–Tumor Barrier

  2025cites this paper
• Terapia corticosteroidea nella pratica reumatologica

  2024cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia in Cancer Patients: A Feasibility Study

  2024cites this paper
• Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus

  2024cites this paper
• Diabetic Kidney Disease in Post-Kidney Transplant Patients

  2024cites this paper
• Glucocorticoid-Induced Hyperglycemia: A Neglected Problem

  2024cites this paper
• Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies

  2024influential citation
• Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study

  2024cites this paper
• Differential effects of oral versus intravenous hydrocortisone and dexamethasone on capillary blood glucose levels in adult inpatients − a single centre study

  2024cites this paper
• The protective effect of imatinib against pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress

  2024cites this paper
• Management of glucocorticoid-induced diabetes

  2024cites this paper
• Multidisciplinary Diabetes Management and Education Strategies in the Inpatient Rehabilitation Setting.

  2024cites this paper
• A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia.

  2023cites this paper
• Effects of steroid stewardship on glycemic control in acute exacerbations of chronic obstructive pulmonary disease patients

  2023cites this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.

  2023cites this paper
• Corticoterapia en la práctica reumatológica

  2023cites this paper
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

  2023cites this paper
• Corticothérapie en pratique rhumatologique

  2023cites this paper
• Public awareness of side effects of systemic steroids in Asir region, Saudi Arabia

  2023cites this paper
• Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey.

  2023cites this paper
• Diabetes Mellitus, Energy Metabolism, and COVID-19

  2023cites this paper
• Necrotizing Fasciitis—Severe Complication of Bullous Pemphigoid: A Systematic Review, Risk Factors, and Treatment Challenges

  2023cites this paper
• Necrotizing fasciitis - a complication of autoimmune skin blistering diseases?

  2023cites this paper
• Steroids Induced Hyperglycemia: Its Effects and Management

  2023cites this paper
• Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

  2023cites this paper
• Microbiota-dependent and -independent effects of obesity on transplant rejection and hyperglycemia.

  2023cites this paper
• Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach.

  2022influential citation
• The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study

  2022cites this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.

  2022cites this paper
• Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations

  2022cites this paper
• Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c

  2022cites this paper
• Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma

  2022cites this paper
• Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders

  2022cites this paper
• Steroid-Induced Diabetic Ketoacidosis: A Case Report and Review of the Literature

  2022cites this paper
• Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial

  2022cites this paper
• Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study

  2022cites this paper
• Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.

  2022influential citation
• Insulin Dosing and Glycemic Outcomes among Steroid-treated Hospitalized Patients.

  2022cites this paper
• Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control

  2022cites this paper
• The effect of metformin on glucose metabolism in patients receiving glucocorticoids.

  2022cites this paper
• Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions

  2022cites this paper
• A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.

  2022cites this paper
• Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.

  2022cites this paper
• Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases

  2021cites this paper
• Profil Pemphigus Vulgaris di Instalasi Rawat Inap RSUD Dr. Moewardi Surakarta Periode Januari 2014-Desember 2019

  2021cites this paper
• Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance

  2021cites this paper
• In-silico Screening of Phytoconstituents on Wound Healing Targets-Approaches and Current Status.

  2021cites this paper
• Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms

  2021cites this paper
• The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study

  2021cites this paper
• Obesity as a Poor Prognostic Factor in Multiple Myeloma

  2021cites this paper
• Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia

  2021cites this paper
• The critical need for guidance in managing glycaemic control in patients with cancer

  2021cites this paper
• Dexamethasone induces pancreatic β-cell apoptosis through upregulation of TRAIL death receptor.

  2021cites this paper
• Current cancer therapies and their influence on glucose control

  2021cites this paper
• Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes

  2021cites this paper
• Nonprescription Corticosteroid Use, Per Capita Consumption and Pattern of Distribution of Commonly Used Corticosteroids in Khuzestan Province Pharmacies Throughout 2016

  2021cites this paper
• Persistent Hyperglycemia in Brain Tumor Patients Treated with Dexamethasone Peri-Operatively and Post-Operatively

  2021cites this paper
• Mitigation of metabolic dyshomeostasis by glucocorticoid-receptor antagonism: Insights from animal and human studies

  2020cites this paper
• Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature

  2020cites this paper
• Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care

  2020cites this paper
• Analysis of Glucocorticoid-Related Genes Reveal CCHCR1 as a New Candidate Gene for Type 2 Diabetes

  2020cites this paper
• Metabolische und endokrine Toxizität antineoplastischer Substanzen

  2020cites this paper
• A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

  2020cites this paper
• High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning

  2020influential citation
• In-vitro Anti-lipoxygenase and Membrane Stabilization Activity of Crude Extracts of Euphorbia lateriflora (Schum and Thonn)

  2020cites this paper
• Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity

  2020cites this paper
• Over-expression of Wilms' tumor 1-associating Protein Promotes Tumorigenesis and Predicts Poor Prognosis in Endometrial Cancer

  2020cites this paper
• Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

  2020cites this paper
• Glucose intolerance in intensive care patients: Incidence and outcome

  2020cites this paper
• Letter to the editor: MITIGATION OF METABOLIC DYSHOMEOSTASIS BY GLUCOCORTICOID- RECEPTOR ANTAGONISM: INSIGHTS FROM ANIMAL AND HUMAN STUDIES

  2020cites this paper
• Safe care for people with diabetes in hospital.

  2020cites this paper
• Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers

  2020cites this paper
• The role of osteocalcin in mechanism of Steroid induced diabetes mellitus

  2020cites this paper
• Effect of short-term prednisone on beta-cell function in subjects with type 2 diabetes mellitus and healthy subjects

  2020cites this paper
• Future technology-enabled care for diabetes and hyperglycemia in the hospital setting

  2019cites this paper
• Prise en charge du diabète en milieu hospitalier Comité d’experts des Lignes directrices de pratique clinique de Diabète Canada

  2019cites this paper
• Type 2 Diabetes Mellitus in Patients with a Prior History of Corticosteroid-induced Hyperglycemia

  2019cites this paper
• Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital

  2019cites this paper
• The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids

  2019cites this paper
• The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis.

  2019cites this paper
• Novel cancer therapies and their association with diabetes.

  2019cites this paper
• Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review

  2019cites this paper
• Inpatient Management of Diabetes and Hyperglycemia

  2019cites this paper